SCHEMBL3546559

SCHEMBL3546559

Nc1ccccc1N1CCCNCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.67
ADRB1 P08588 3/20 0.55
ADRA2C P18825 1/20 0.53
HTR6 P50406 4/20 0.50
HTR7 P34969 4/20 0.50
HTR1A P08908 4/20 0.50
HTR3A P46098 4/20 0.50
HTR2A P28223 2/20 0.50
HTR5A P47898 2/20 0.50
HTR3E A5X5Y0 2/20 0.50
HTR3B O95264 2/20 0.50
HTR3D Q70Z44 2/20 0.50
HTR3C Q8WXA8 2/20 0.50
SIGMAR1 Q99720 2/20 0.50
NCF1 P14598 2/20 0.50
HTR2B P41595 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532010 0.93 KEAP1 (0.64) KEAP1ADRB1ADRA2CHTR6HTR7
Hydrochloric Acid SCHEMBL4684126 0.91 KEAP1 (0.62) KEAP1ADRB1ADRA2CHTR6HTR7
SCHEMBL29938274 0.82 KEAP1 (0.95) KEAP1ADRA2CNCF1HSD17B10MEN1
SCHEMBL30664040 0.82 KEAP1 (0.87) KEAP1ADRA2CNCF1HSD17B10MEN1
SCHEMBL484010 0.82 KEAP1 (0.95) KEAP1ADRA2CNCF1HSD17B10MEN1
SCHEMBL27597451 0.81 KEAP1 (0.55) KEAP1ADRB1ADRA2CHTR6HTR7
SCHEMBL17738698 0.81 KEAP1 (0.44) KEAP1ADRB1HTR6HTR7HTR1A
SCHEMBL73609 0.81 KEAP1 (1.00) KEAP1ADRA2CNCF1HSD17B10MEN1
SCHEMBL17276365 0.81 ADRB1 (0.67) ADRB1HTR6HTR7HTR1AHTR3A
SCHEMBL22652955 0.81 ADRB1 (0.67) ADRB1HTR6HTR7HTR1AHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163746-B2 Azolecarboxamide derivative ASTELLAS PHARMA INC. (JP) 2012-04-24 US disclosed
US-20090286766-A1 AZOLECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286766-A1 AZOLECARBOXAMIDE DERIVATIVE GPR17, NTRK1, TRPV1 KEAP1 1485/4885ADRB1 37/4885ADRA2C 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.